The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
HGF reduces advancing lung fibrosis in mice: a potential role for MMP‐dependent myofibroblast apoptosis
Abstract
Pulmonary fibrosis is characterized by a loss of lung epithelial cells, replaced by interstitial myofibroblasts to deposit extracellular matrix (ECM) proteins. Previous studies demonstrated that hepatocyte growth factor (HGF) improved lung fibrosis in murine models, whereas molecular mechanisms whereby HGF improved lung fibrosis have yet to be fully understood. When MRC-5 human lung fibroblasts were treated with transforming growth factor-beta1, the cells underwent phenotypic change similar to myofibroblasts and this was associated with up-regulation of c-Met/HGF receptor expression. For the myofibroblast-like cells, HGF increased activities of MMP-2/-9, predominant enzymes for breakdown of fibronectin (FN). Under such conditions, HGF induced caspase-dependent apoptosis, linked with a decrease in a FN central cell binding (CCB) domain involved in FAK phosphorylation. When MMI270 (a broad-spectrum MMP inhibitor) was added together with HGF, decreases in FN-CCB domain expression and FAK phosphorylation by HGF were restored, and these events were associated with an inhibition of HGF-induced apoptosis, suggesting that increased activities of MMPs underlie the major mechanism of HGF-mediated apoptosis in myofibroblasts. In bleomycin-treated mice, c-Met expression was found on interstitial myofibroblasts and HGF increased apoptosis in culture of myofibroblasts isolated from bleomycin-treated murine lungs. Furthermore, administration of recombinant HGF to bleomycin-treated mice incr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased MET signalling ameliorates disease pathogenesis in several models of classic systemic inflammatory diseases, including multiple sclerosis and systemic lupus erythematosis (SLE) among others38–42.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [42]
Citations
Cites
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 1×
“Interstitial FN is important for cell survival that depends on anchorage to ECM (26, 27), while HGF enhances apoptotic cell death under FN-deficient conditions (28).”
BackgroundMet, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602 · cited 1×
“There is now ample evidence that HGF plays an essential part in parenchymal repair and protection in various organs (13, 14).”
BackgroundMolecular cloning and expression of human hepatocyte growth factor
Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., & Shimizu, S. (1989) · Nature · doi:10.1038/342440a0 · Cited by 2,157 · cited 1×
“Hepatocyte growth factor (HGF) was identified and cloned as a mitogen for mature hepatocytes (11, 12).”
BackgroundSelf-citationNakamura, T., Nawa, K., & Ichihara, A. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91253-1 · Cited by 1,134 · cited 1×
“Hepatocyte growth factor (HGF) was identified and cloned as a mitogen for mature hepatocytes (11, 12).”
BackgroundSelf-citationIredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 4×
“Considering that not only myofibroblast depletion but also ECM disappearance is required for reversing fibrosis (9, 10), such an apoptotic mechanism seems to be physiologically adaptable for these purposes.”
BackgroundInfluentialGross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
Molecular mechanisms of “detachment-induced apoptosis—Anoikis”
Grossmann, J. (2002) · Apoptosis · doi:10.1023/a:1015312119693 · Cited by 565 · cited 1×
“Perhaps, the loss in survival signals via FN/FAK may play a predominant role in onset of HGF-induced apoptosis in myofibroblasts presumably as if cells undergo “anoikis” (34), apoptotic cell death induced by a loss of anchorage to the extracellular substrate.”
BackgroundThe Myofibroblast in Pulmonary Fibrosis*
Phan, S. H. (2002) · Chest · doi:10.1378/chest.122.6_suppl.286s · Cited by 521
Zhang, K., Rekhter, M. D., Gordon, D., & Phan, S. H. (1994) · PubMed · Cited by 480
Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., & Nakamura, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10226 · Cited by 434 · cited 1×
“For a variety of cells, HGF has anti-apoptotic action (31, 32), whereas HGF has the potential to stimulate apoptotic cell death in some distinct types of cells, including transformed or neoplastic cells (33), indicating that HGF biologically regulates cell survival in a cell type-dependent manner.”
BackgroundSelf-citation
Research works printed but not linked: 2
- 10.1210/en.140.6.2908 · doi:10.1210/en.140.6.2908
- Fukuda Y., 1998, Localization of matrix metalloproteinases-1, −2, and −9 and tissue inhibitor of metalloproteinase-2, Lab. Invest., 78, 687
Cited by
The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
Ho, W. J., Jaffee, E. M., & Zheng, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0363-5 · Cited by 1,287
MET signalling: principles and functions in development, organ regeneration and cancer
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3012 · Cited by 1,240
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
NAKAMURA, T., & MIZUNO, S. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.588 · Cited by 547
Self-citation
Metadata
- Authors
- Mizuno, S., Matsumoto, K., Li, M.-Y., & Nakamura, T.
- Affiliations
- The University of Osaka (JP)
- Division of Molecular Regenerative Medicine Department of Molecular Regenerative Medicine Osaka University Graduate School of Medicine Yamadaoka 2-2-B7 Suita 565-0871 Japan
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-01-21
- Volume
- 19
- Issue
- 6
- Pages
- 1-18
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2107066838
- Cited by
- 177
- References
- 48
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 12 · 2019: 7 · 2018: 9 · 2017: 5 · 2016: 6 · 2015: 9 · 2014: 9 · 2013: 5 · 2012: 13
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Science and Technology (12215082, 14207005, 16590312)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- hepatocyte growth factor, pulmonary fibrosis, myofibroblast apoptosis, matrix metalloproteinases, MMP-2, MMP-9, fibronectin, c-Met, FAK phosphorylation, caspase-dependent apoptosis, extracellular matrix degradation, bleomycin-induced lung fibrosis, MRC-5 fibroblasts, TGF-β1
- MeSH terms
- Actins, Animals, Bleomycin, Cell Line, Enzyme Inhibitors, Fibroblasts, Fibronectins, Humans, Hydroxamic Acids, Lung, Mice, Inbred C57BL, Pulmonary Fibrosis, Pyrazines, Recombinant Proteins, Sulfonamides, Tissue Distribution, Signal Transduction, Apoptosis, Hepatocyte Growth Factor, Proto-Oncogene Proteins c-met, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Matrix Metalloproteinases, Muscle Cells, Mice, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HGF reduces advancing lung fibrosis in mice: a potential role for MMP‐dependent myofibroblast apoptosis. https://app.cochat.ai/papers/10.1096/fj.04-1535fje
- The paper
- Mizuno, S., Matsumoto, K., Li, M.-Y., & Nakamura, T. (2005). HGF reduces advancing lung fibrosis in mice: a potential role for MMP‐dependent myofibroblast apoptosis. The FASEB Journal. https://doi.org/10.1096/fj.04-1535fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.